VYNE Therapeutics Financial Overview
VYNE Therapeutics's market cap is currently $19.97M. The company's EPS TTM is $-0.17; its P/E ratio is -0.74; VYNE Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
